Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

21st-Jan-2013 12:20Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives final approvals for Oxacillin Injections

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials (ANDA 201539) and Oxacillin for Injection USP 10g/Vial Pharmacy Bulk Package (ANDA 201538). The products are ready for launch.

Sections
Follow us on
Available On